NO753455L - - Google Patents

Info

Publication number
NO753455L
NO753455L NO753455A NO753455A NO753455L NO 753455 L NO753455 L NO 753455L NO 753455 A NO753455 A NO 753455A NO 753455 A NO753455 A NO 753455A NO 753455 L NO753455 L NO 753455L
Authority
NO
Norway
Application number
NO753455A
Other languages
Norwegian (no)
Other versions
NO140824B (no
NO140824C (no
Inventor
K Petzoldt
H-J Vidic
K Prezewowsky
Y Nishino
R Wiechert
H Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2449327A external-priority patent/DE2449327C2/de
Priority claimed from DE19752535997 external-priority patent/DE2535997A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO753455L publication Critical patent/NO753455L/no
Publication of NO140824B publication Critical patent/NO140824B/no
Publication of NO140824C publication Critical patent/NO140824C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/912—Absidia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/939—Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO753455A 1974-10-14 1975-10-13 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener NO140824C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2449327A DE2449327C2 (de) 1974-10-14 1974-10-14 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19752535997 DE2535997A1 (de) 1975-08-08 1975-08-08 7-hydroxy-oestradiole

Publications (3)

Publication Number Publication Date
NO753455L true NO753455L (cg-RX-API-DMAC7.html) 1976-04-20
NO140824B NO140824B (no) 1979-08-13
NO140824C NO140824C (no) 1979-11-21

Family

ID=25767825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO753455A NO140824C (no) 1974-10-14 1975-10-13 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener

Country Status (23)

Country Link
US (1) US4011314A (cg-RX-API-DMAC7.html)
JP (1) JPS5165747A (cg-RX-API-DMAC7.html)
AT (1) AT348695B (cg-RX-API-DMAC7.html)
CA (1) CA1054143A (cg-RX-API-DMAC7.html)
CH (2) CH619240A5 (cg-RX-API-DMAC7.html)
CS (2) CS205010B2 (cg-RX-API-DMAC7.html)
DD (1) DD125588A5 (cg-RX-API-DMAC7.html)
DK (1) DK135378C (cg-RX-API-DMAC7.html)
ES (1) ES441784A1 (cg-RX-API-DMAC7.html)
FI (1) FI54603C (cg-RX-API-DMAC7.html)
FR (1) FR2287908A1 (cg-RX-API-DMAC7.html)
GB (1) GB1528796A (cg-RX-API-DMAC7.html)
HU (1) HU176715B (cg-RX-API-DMAC7.html)
IE (1) IE42167B1 (cg-RX-API-DMAC7.html)
IL (1) IL48276A (cg-RX-API-DMAC7.html)
NL (1) NL7512041A (cg-RX-API-DMAC7.html)
NO (1) NO140824C (cg-RX-API-DMAC7.html)
NZ (1) NZ178886A (cg-RX-API-DMAC7.html)
PH (1) PH13802A (cg-RX-API-DMAC7.html)
PL (2) PL103989B1 (cg-RX-API-DMAC7.html)
SE (1) SE405254B (cg-RX-API-DMAC7.html)
SU (2) SU676170A3 (cg-RX-API-DMAC7.html)
YU (2) YU243975A (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997037664A2 (en) 1996-04-09 1997-10-16 British Technology Group Ltd. Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
PL1624878T3 (pl) * 2003-05-22 2007-01-31 Pantarhei Bioscience Bv Zastosowanie kompozycji zawierającej estrogenowy składnik w celu leczenia i zapobiegania bólowi mięśniowo-szkieletowemu
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115444A (en) * 1962-01-22 1963-12-24 Olin Mathieson Process for microbial hydroxylation of steroids containing aromatic alpha-rings

Also Published As

Publication number Publication date
AU8571075A (en) 1977-04-21
GB1528796A (en) 1978-10-18
SE405254B (sv) 1978-11-27
DK439975A (da) 1976-04-15
CS205010B2 (en) 1981-04-30
DK135378B (da) 1977-04-18
SU677666A1 (ru) 1981-11-30
YU294281A (en) 1982-06-30
CS205009B2 (en) 1981-04-30
YU243975A (en) 1982-06-30
ATA775475A (de) 1978-07-15
CH619268A5 (cg-RX-API-DMAC7.html) 1980-09-15
NO140824B (no) 1979-08-13
CH619240A5 (cg-RX-API-DMAC7.html) 1980-09-15
AT348695B (de) 1979-02-26
PL103989B1 (pl) 1979-07-31
NL7512041A (nl) 1976-04-20
NZ178886A (en) 1978-04-28
NO140824C (no) 1979-11-21
JPS5165747A (en) 1976-06-07
SU676170A3 (ru) 1979-07-25
CA1054143A (en) 1979-05-08
IL48276A (en) 1979-03-12
FR2287908B1 (cg-RX-API-DMAC7.html) 1980-04-30
FI54603B (fi) 1978-09-29
DD125588A5 (cg-RX-API-DMAC7.html) 1977-05-04
ES441784A1 (es) 1977-04-01
PL101461B1 (pl) 1978-12-30
IE42167L (en) 1976-04-14
DK135378C (da) 1977-10-03
PH13802A (en) 1980-10-01
US4011314A (en) 1977-03-08
FI752836A7 (cg-RX-API-DMAC7.html) 1976-04-15
SE7511438L (sv) 1976-04-15
FI54603C (fi) 1979-01-10
IL48276A0 (en) 1975-12-31
IE42167B1 (en) 1980-06-18
HU176715B (en) 1981-04-28
FR2287908A1 (fr) 1976-05-14
SU677666A3 (en) 1981-11-30

Similar Documents

Publication Publication Date Title
FR2287908B1 (cg-RX-API-DMAC7.html)
FI750099A7 (cg-RX-API-DMAC7.html)
DK97775A (cg-RX-API-DMAC7.html)
CS173028B1 (cg-RX-API-DMAC7.html)
AU495870B2 (cg-RX-API-DMAC7.html)
AU7478474A (cg-RX-API-DMAC7.html)
AU7470174A (cg-RX-API-DMAC7.html)
AU7253374A (cg-RX-API-DMAC7.html)
CS174926B1 (cg-RX-API-DMAC7.html)
AU8476175A (cg-RX-API-DMAC7.html)
FI740312A0 (cg-RX-API-DMAC7.html)
AU479624A (cg-RX-API-DMAC7.html)
BG19967A1 (cg-RX-API-DMAC7.html)
AU482294A (cg-RX-API-DMAC7.html)
BG20141A1 (cg-RX-API-DMAC7.html)
BG19682A1 (cg-RX-API-DMAC7.html)
BG19713A1 (cg-RX-API-DMAC7.html)
CH595132A5 (cg-RX-API-DMAC7.html)
BG20045A1 (cg-RX-API-DMAC7.html)
BG19993A1 (cg-RX-API-DMAC7.html)
AU480902A (cg-RX-API-DMAC7.html)
DD115341A1 (cg-RX-API-DMAC7.html)
BG19872A1 (cg-RX-API-DMAC7.html)
DD122077A5 (cg-RX-API-DMAC7.html)
BG19890A1 (cg-RX-API-DMAC7.html)